Exchange: NASDAQ·Updated 01:09 PM EDT
PCSA logo

PCSA Processa Pharmaceuticals Inc

$1.89
$0.00
(0.00%)
Today
Reported EarningsAug 7
Mkt Cap$5.28M
Vol1,561.00

About PCSA

Processa Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drug products for the treatment of serious medical conditions. Its main product candidate is PCS499, which is intended for the treatment of Necrobiosis Lipoidica. The company was founded by David Young, Patrick Lin, Sian E. Bigora, Wendy Guy, and Chang Rung Chen on March 29, 2011 and is headquartered in Vero Beach, FL.
43

Bearish Sentiment

How do you feel about PCSA?

GJ_Rockabilt
$PCSA No thanks, I think I'll stick with my $BFRI recent FDA Approval. I'm not Buying it, on this PCSA uptick, PreMarket. New Officers want new free Shares?
Jwa68
$PCSA I'm frankly surprised at the lack of any meaningful price appreciation with former management now gone and 6422 returned to its owner along with a nice settlement payment courtesy of long suffering shareholders. Meanwhile George, David, Russell, Wendy and Patrick all likely got, or continue to get, their nearly 2M in comp while destroying shareholder value to a tune of 99.8% on their watch. I wonder how they sleep at night frankly. They even left a shareholder lawsuit for the new company. Not a good look for new potential investors in my opinion. Let's hope new management is not cut from the same cloth as former. Lots of goodwill to be reestablished if they hope to not continue in the footsteps of those they replaced. Poor and untrustworthy management, missed guidance, failed promises, lawsuits, free shares to themselves, egregious comp packages, no accountability, some stock promotion, multiple reverse splits and tremendous dilution. Most would suggest the old team set the bar pretty low for the new management team. I hope they learn something from the actions of their predecessors and do completely the opposite.
_ChasingLambos
$PCSA holding. Also adding NCRA from $2.05. Low float + 0 short shares available + 300%+ CTB + ~$3M market cap + AI/Micron exposure = serious potential if volume hits.

Advertisement|Remove ads.